GO
Loading...

Novartis Ruling Won't Affect India Investment

Monday, 1 Apr 2013 | 6:40 PM ET

Damien Conover, Healthcare Strategist at Morningstar says that India remains a crucial emerging market for global pharmaceutical companies, despite the negative ruling on Novartis' patent case.